Tag: pet diabetes care market growth

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Pet Diabetes Care Market Grown from 2024 to 2025?

In recent years, there has been significant growth in the market size for pet diabetes care. It is predicted that this market will expand from $2.21 billion in 2024 to $2.41 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%. The growth witnessed over the historical period is due to several factors such as increased awareness of pet health, developments in veterinary medicine, escalating instances of diabetes among pets, perceiving pets as humans, greater emphasis on pet nutrition, awareness drives by veterinary entities, and the availability of insulin and other medicines.

What Growth Rate Is Anticipated for the Pet Diabetes Care Market in the Coming Years?

In the coming years, the market size for pet diabetes care is expected to experience significant growth. By 2029, it is projected to reach $3.49 billion, with a compound annual growth rate (CAGR) of 9.7%. The anticipated growth in the forecast period is due to various factors such as the increase in pet insurance adoption, bespoke diabetes management plans for pets, emphasis on preventive pet healthcare, the expansion of pet health trends globally, along with increased investments in pet healthcare research, and a rise in consumer affluence. Major upcoming trends in the forecast period consist of advancements in veterinary diagnostics, attention towards managing pet obesity, innovation in insulin delivery systems, an increase in pet insurance coverage, an expanded availability of specialized pet foods, the use of telemedicine and remote monitoring, and collaborative efforts in veterinary medicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

Who Are the Leading Companies in the Pet Diabetes Care Market?

Major companies operating in the pet diabetes care market are C.H. Boehringer Sohn AG & Co. KG, Becton Dickinson and Company, Merck & Co Inc., Zoetis Inc., Trividia Health Inc., Allison Medical Inc., UltiMed Inc., Apotex Inc., Henry Schein VET GmbH, Medtrust Holdings Inc., i-SENS Inc., Taidoc Technology Corp., Covetrus Inc., ALR Technologies Inc., Vet Innovations Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG, Bayer AG, Dexcom Inc., LifeScan Inc., Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., Senseonics Holdings Inc., Tandem Diabetes Care Inc., Terumo Corporation, Animas Corporation, Insulet Corporation, Roche Diabetes Care Inc.

What Are the Key Drivers of the Pet Diabetes Care Market?

The anticipated rise in pet adoption is projected to boost the expansion of the pet diabetes care market. Adopting a pet involves acquiring a pet from an animal shelter or rescue organization where it has been abandoned by its previous owners, in contrast to purchasing one from a pet store, breeder, or other private entities. The annual incidence of diabetes diagnosis in pets is on the rise, largely due to their lifestyles reflecting ours, being less active and relying more on processed foods. For instance, Animal Medicines Australia, an Australian non-governmental organization, reported a significant rise in pet ownership in 2022. The number of pet owners increased to 28,730.8 in 2022, from 39% in 2021, representing a 24% increase, signifying a firm increase in pet adoption and spending on care. A surge in pet ownership brings attention to the growing popularity of pets in Australian homes. Accordingly, the pet diabetes care market is seeing growth driven by an increase in pet adoption.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8095&type=smp

What Are the Key Market Segments in the Pet Diabetes Care Industry?

The pet diabetes care market covered in this report is segmented –

1) By Drug Type: Insulin Therapy, Oral Medication

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices

3) By Animal Type: Canine, Feline, Other Animal Types

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals

Subsegments:

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices

2) By Oral Medication: Glipizide, Metformin, Other Oral Hypoglycemic Agents

What Are the Latest Trends in the Pet Diabetes Care Market?

The surge in research and development operations paired with the introduction of novel products is becoming more prevalent in the pet diabetes sector. A plethora of research is underway to gain a deeper comprehension of diabetes in pets and to improve its treatment. Additionally, in a bid to secure their market standing, firms are producing new offerings, such as generic drugs. Elanco Animal Health Inc. received approval from the U.S. Food and Drug Administration (FDA), a scientific regulatory body, in December 2022 for a breakthrough medication for cats suffering from a particular type of diabetes. This marks it as the first animal-approved oral drug for this illness.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

What Are the Key Regional Markets in the Pet Diabetes Care Industry?

North America was the largest region in the pet diabetes care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8095

This Report Delivers Insight On:

1. How big is the pet diabetes care market, and how is it changing globally?

2. Who are the major companies in the pet diabetes care market, and how are they performing?

3. What are the key opportunities and risks in the pet diabetes care market right now?

4. Which products or customer segments are growing the most in the pet diabetes care market?

5. What factors are helping or slowing down the growth of the pet diabetes care market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Pet Diabetes Care Market Grown from 2024 to 2025?

In recent years, there has been significant growth in the market size for pet diabetes care. It is predicted that this market will expand from $2.21 billion in 2024 to $2.41 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%. The growth witnessed over the historical period is due to several factors such as increased awareness of pet health, developments in veterinary medicine, escalating instances of diabetes among pets, perceiving pets as humans, greater emphasis on pet nutrition, awareness drives by veterinary entities, and the availability of insulin and other medicines.

What Growth Rate Is Anticipated for the Pet Diabetes Care Market in the Coming Years?

In the coming years, the market size for pet diabetes care is expected to experience significant growth. By 2029, it is projected to reach $3.49 billion, with a compound annual growth rate (CAGR) of 9.7%. The anticipated growth in the forecast period is due to various factors such as the increase in pet insurance adoption, bespoke diabetes management plans for pets, emphasis on preventive pet healthcare, the expansion of pet health trends globally, along with increased investments in pet healthcare research, and a rise in consumer affluence. Major upcoming trends in the forecast period consist of advancements in veterinary diagnostics, attention towards managing pet obesity, innovation in insulin delivery systems, an increase in pet insurance coverage, an expanded availability of specialized pet foods, the use of telemedicine and remote monitoring, and collaborative efforts in veterinary medicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

Who Are the Leading Companies in the Pet Diabetes Care Market?

Major companies operating in the pet diabetes care market are C.H. Boehringer Sohn AG & Co. KG, Becton Dickinson and Company, Merck & Co Inc., Zoetis Inc., Trividia Health Inc., Allison Medical Inc., UltiMed Inc., Apotex Inc., Henry Schein VET GmbH, Medtrust Holdings Inc., i-SENS Inc., Taidoc Technology Corp., Covetrus Inc., ALR Technologies Inc., Vet Innovations Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG, Bayer AG, Dexcom Inc., LifeScan Inc., Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., Senseonics Holdings Inc., Tandem Diabetes Care Inc., Terumo Corporation, Animas Corporation, Insulet Corporation, Roche Diabetes Care Inc.

What Are the Key Drivers of the Pet Diabetes Care Market?

The anticipated rise in pet adoption is projected to boost the expansion of the pet diabetes care market. Adopting a pet involves acquiring a pet from an animal shelter or rescue organization where it has been abandoned by its previous owners, in contrast to purchasing one from a pet store, breeder, or other private entities. The annual incidence of diabetes diagnosis in pets is on the rise, largely due to their lifestyles reflecting ours, being less active and relying more on processed foods. For instance, Animal Medicines Australia, an Australian non-governmental organization, reported a significant rise in pet ownership in 2022. The number of pet owners increased to 28,730.8 in 2022, from 39% in 2021, representing a 24% increase, signifying a firm increase in pet adoption and spending on care. A surge in pet ownership brings attention to the growing popularity of pets in Australian homes. Accordingly, the pet diabetes care market is seeing growth driven by an increase in pet adoption.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8095&type=smp

What Are the Key Market Segments in the Pet Diabetes Care Industry?

The pet diabetes care market covered in this report is segmented –

1) By Drug Type: Insulin Therapy, Oral Medication

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices

3) By Animal Type: Canine, Feline, Other Animal Types

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals

Subsegments:

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices

2) By Oral Medication: Glipizide, Metformin, Other Oral Hypoglycemic Agents

What Are the Latest Trends in the Pet Diabetes Care Market?

The surge in research and development operations paired with the introduction of novel products is becoming more prevalent in the pet diabetes sector. A plethora of research is underway to gain a deeper comprehension of diabetes in pets and to improve its treatment. Additionally, in a bid to secure their market standing, firms are producing new offerings, such as generic drugs. Elanco Animal Health Inc. received approval from the U.S. Food and Drug Administration (FDA), a scientific regulatory body, in December 2022 for a breakthrough medication for cats suffering from a particular type of diabetes. This marks it as the first animal-approved oral drug for this illness.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

What Are the Key Regional Markets in the Pet Diabetes Care Industry?

North America was the largest region in the pet diabetes care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8095

This Report Delivers Insight On:

1. How big is the pet diabetes care market, and how is it changing globally?

2. Who are the major companies in the pet diabetes care market, and how are they performing?

3. What are the key opportunities and risks in the pet diabetes care market right now?

4. Which products or customer segments are growing the most in the pet diabetes care market?

5. What factors are helping or slowing down the growth of the pet diabetes care market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the pet diabetes care industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Pet Diabetes Care Market In 2029?

In recent periods, the size of the pet diabetes care market has experienced solid growth. It is predicted to expand from a valuation of $2.21 billion in 2024 to $2.41 billion in 2025, representing a compound annual growth rate (CAGR) of 8.9%. The expansion during the historic period can be ascribed to factors such as enhanced consciousness about pet health, progress in the field of veterinary medicine, the incidence of diabetes in pets, treating pets with a human-like regard, heightened emphasis on pet nutrition, informative campaigns run by veterinary institutions, and the accessibility of insulin and other medications.

Expectations suggest robust expansion in the pet diabetes care market in the upcoming years, potentially reaching $3.49 billion by 2029 with a compound annual growth rate (CAGR) of 9.7%. This surge during the forecast period is linked to the escalating adoption of pet insurance, the development of personalized diabetes management programs, the focus on pro-active pet healthcare, the international influence on pet healthcare tendencies, the boost in pet healthcare research investment and the increasing abundance of consumers. The forecast period also signifies major trends that include advancements in the field of veterinary diagnostics, prioritizing pet obesity management, innovating insulin delivery methods, increasing pet insurance offerings, greater accessibility to unique pet foods, telemonitoring and telemedicine, and partnerships in veterinary medicine.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

What are the Fundamental Drivers and Innovations Shaping the Pet Diabetes Care Market?

The anticipated rise in pet adoption is predicted to drive the expansion of the pet diabetes care market. Acquiring a pet from a shelter or rescue that has been abandoned by its previous owners denotes pet adoption, in contrast to purchasing a pet from a pet store, breeder, or any other person. The annual detection of diabetes in pets is on the rise, which is to some extent because their day-to-day habits are highly similar to ours in terms of being less active and depending largely on processed food. For instance, Animal Medicines Australia, an Australian non-governmental organization, noticed a marked increase in pet ownership in 2022, with pet owners hitting the figure of 28,730.8 in that same year, ascending from 39% in 2021. This equals a 24% increase, portraying a significant rise in pet adoption and expenditure on care. The swell in pet ownership indicates the escalating trend of pet keeping in Australian homes. Therefore, the rise in pet adoption is fuelling the expansion of the pet diabetes care market.

How Is the Pet Diabetes Care Market Segmented?

The pet diabetes care market covered in this report is segmented –

1) By Drug Type: Insulin Therapy, Oral Medication

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices

3) By Animal Type: Canine, Feline, Other Animal Types

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals

Subsegments:

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices

2) By Oral Medication: Glipizide, Metformin, Other Oral Hypoglycemic Agents

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=8095&type=smp

Which Regions Are Driving the Next Phase of the Pet Diabetes Care Market Growth?

North America was the largest region in the pet diabetes care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Pet Diabetes Care Market?

The propagation of research and development efforts along with the introduction of new offerings are the emerging trends seen in the pet diabetes market. A number of studies are being conducted on animal diabetes to have a deeper comprehension of the disease and facilitate easier management. Furthermore, corporations are coming up with new goods, including generic medications, to maintain their place in the industry. The U.S. Food and Drug Administration (FDA), a scientific regulatory body, gave its approval in December 2022 to a drug developed by Elanco Animal Health Inc. for feline patients diagnosed with a specific form of diabetes, marking it as the inaugural oral treatment approved for such a condition in animals.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

How Is the Pet Diabetes Care Market Defined and What Are Its Core Parameters?

Pet diabetes care is used to treat pets suffering from diabetes, which may also cause other diseases such as heart disease, pancreatitis, urinary tract infections, kidney disease, and skin infections. Diabetes develops when a pet’s body produces insufficient insulin, stops generating it altogether, or uses it improperly, which hinders the body from converting food into energy.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8095

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Pet Diabetes Care Market?

The pet diabetes care market is anticipated to experience growth due to an expected rise in pet adoption. Pet adoption usually involves acquiring a pet from a shelter or rescue group that has been abandoned by its previous owners, rather than purchasing one from a pet store, breeder, or private individuals. Pets are being diagnosed with diabetes more frequently each year, partly as their lifestyles begin to resemble ours, characterized by reduced activity levels and greater dependence on processed foods. For instance, Animal Medicines Australia, an Australian non-governmental organization, documented a notable rise in pet ownership in 2022. They reported the number of pet owners stood at 28,730.8 in 2022, a jump from 39% in the previous year, representing a 24% increase. This reveals a robust uptick in pet adoption and commitment to their care. The leap in pet ownership underscores the growing preference for pets in Australian homes. Consequently, the rise in pet adoption rates is fuelling the expansion of the pet diabetes care market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

How Will the Growth Rate of thePet Diabetes Care Market Impact Industry Trends by 2034?

The size of the pet diabetes care market has seen substantial growth lately and is projected to rise from $2.21 billion in 2024, reaching $2.41 billion in 2025 with a compound annual growth rate (CAGR) of 8.9%. Key factors contributing to this development in the historic period include enhanced consciousness about pet health, advancements in the field of veterinary medicine, increased instances of diabetes in pets, treating pets with human-like care, heightened emphasis on pet nutrition, educational campaigns by veterinary institutions, and increased accessibility of insulin and medications.

Strong expansion is anticipated in the pet diabetes care market in the upcoming years, with its worth predicted to reach $3.49 billion by 2029, reflecting a compound annual growth rate (CAGR) of 9.7%. The projected growth in this period can be credited to increased pet insurance enrollment, tailored diabetes treatment plans, emphasis on preventive pet healthcare, the globalization of pet health patterns, escalated investments in pet healthcare studies, and climbing consumer wealth. The forecast period will be marked by significant developments in veterinary diagnostics, a heightened focus on pet obesity management, innovation in insulin delivery mechanisms, an expansion in pet insurance provisions, heightened access to specialized pet food, the advent of telemedicine and remote monitoring, and cooperative efforts in veterinary medicine.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8095

What New Market Trends Are Reshaping thePet Diabetes Care Market and Its Opportunities?

Enhanced R&D activities and the introduction of innovative products are becoming popular trends in the pet diabetes market. Extensive research is underway to gain a better understanding of diabetes in pets and simplify its management. Further, to maintain their market position, companies are introducing new offerings, like generic drugs. The U.S. Food and Drug Administration (FDA), a scientific regulatory body, approved a medication for a particular type of diabetes in cats, in December 2022. This drug, produced by Elanco Animal Health Inc., is the first orally administered medication approved for animals with this condition.

Who Are the Leading Market Players Fueling Growth in the Pet Diabetes Care Market Trend?

Major companies operating in the pet diabetes care market are C.H. Boehringer Sohn AG & Co. KG, Becton Dickinson and Company, Merck & Co Inc., Zoetis Inc., Trividia Health Inc., Allison Medical Inc., UltiMed Inc., Apotex Inc., Henry Schein VET GmbH, Medtrust Holdings Inc., i-SENS Inc., Taidoc Technology Corp., Covetrus Inc., ALR Technologies Inc., Vet Innovations Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG, Bayer AG, Dexcom Inc., LifeScan Inc., Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., Senseonics Holdings Inc., Tandem Diabetes Care Inc., Terumo Corporation, Animas Corporation, Insulet Corporation, Roche Diabetes Care Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

How is the Global Pet Diabetes Care Market Segemented?

The pet diabetes care market covered in this report is segmented –

1) By Drug Type: Insulin Therapy, Oral Medication

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices

3) By Animal Type: Canine, Feline, Other Animal Types

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals

Subsegments:

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices

2) By Oral Medication: Glipizide, Metformin, Other Oral Hypoglycemic Agents

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=8095&type=smpGlobal Pet Diabetes Care Market, Global Pet Diabetes Care Market Report, Global Pet Diabetes Care Market Trends, Global Pet Diabetes Care Market Size

Browse Through More Reports Similar to the Gobal Pet Diabetes Care Maret 2025, By The Business Research Company:

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Veterinary Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-healthcare-global-market-report

Veterinary Pain Management Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the pet diabetes care market grown in recent years?

In recent times, the pet diabetes care market has witnessed a significant expansion. It is forecasted to rise from $2.21 billion in 2024 to $2.41 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%. The surge during the past period can be traced back to several factors, including increased awareness about pet health, advancements in veterinary medicine, rising incidences of diabetes in pets, the humanization of pets, enhanced emphasis on pet nutrition, publicity initiatives by veterinary bodies, and accessibility of insulin and medical treatments.

How is the pet diabetes care market size expected to evolve during the forecast period?

Anticipations predict a significant escalation in the pet diabetes care market size in the coming years, expanding to $3.49 billion in 2029 with an impressive compound annual growth rate (CAGR) of 9.7%. The projected upswing during the forecast period can be accredited to factors such as the soaring adoption of pet insurance, bespoke diabetes management plans, emphasis on preventive pet healthcare, internationalization of pet health trends, along with an uptick in investment for pet healthcare research, and growing consumer affluence. Noteworthy trends predicted in the forecast period encompass progress in veterinary diagnostics, focus on combating pet obesity, innovation in insulin delivery systems, expanded pet insurance coverage, proliferation of specialized pet foods, adoption of telemedicine and remote monitoring, as well as partnerships in the field of veterinary medicine.

Get your pet diabetes care market report here!

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

Which key drivers are propelling the pet diabetes care market’s growth?

The upward trajectory of the pet diabetes care market is projected to be fueled by a rise in pet adoptions. Pet adoption involves acquiring a pet from rescue centres or shelters, which were previously owned and then abandoned, rather than purchasing them from pet shops, breeders, or private individuals. The growth in the diagnosis of diabetes in pets each year is primarily due to the fact that they lead lives similar to ours, becoming more sedentary and dependent on processed food. For instance, Animal Medicines Australia, a non-governmental organization located in Australia, disclosed notable growth in pet ownership in 2022, with a rise to 28,730.8 pet owners, a jump from 39% in 2021. This indicates a 24% hike, underscoring a marked increase in not just pet adoption but also expenditure in their care. The rise in pet ownership accentuates the growing role pets play in Australian homes. As a result, the burgeoning pet adoption trend is influencing the expansion of the pet diabetes care market.

What are the market segments in the pet diabetes care industry?

The pet diabetes care market covered in this report is segmented –

1) By Drug Type: Insulin Therapy, Oral Medication

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices

3) By Animal Type: Canine, Feline, Other Animal Types

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals

Subsegments:

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices

2) By Oral Medication: Glipizide, Metformin, Other Oral Hypoglycemic Agents

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

Which leading companies are shaping the growth of the pet diabetes care market?

Major companies operating in the pet diabetes care market are C.H. Boehringer Sohn AG & Co. KG, Becton Dickinson and Company, Merck & Co Inc., Zoetis Inc., Trividia Health Inc., Allison Medical Inc., UltiMed Inc., Apotex Inc., Henry Schein VET GmbH, Medtrust Holdings Inc., i-SENS Inc., Taidoc Technology Corp., Covetrus Inc., ALR Technologies Inc., Vet Innovations Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG, Bayer AG, Dexcom Inc., LifeScan Inc., Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., Senseonics Holdings Inc., Tandem Diabetes Care Inc., Terumo Corporation, Animas Corporation, Insulet Corporation, Roche Diabetes Care Inc.

What key trends are currently impacting the pet diabetes care market’s development?

Rising research and innovation initiatives along with the introduction of new solutions are becoming increasingly prominent trends in the pet diabetes industry. A host of studies are underway to deepen the understanding of diabetes in animals with the aim to make its management less challenging. In addition, businesses are unveiling novel offerings, including generic medications, with the aim to maintain their market standing. For instance, in December 2022, the U.S. Food and Drug Administration (FDA), a scientific oversight entity, green-lit a medication produced by Elanco Animal Health Inc., intended for cats afflicted by a particular form of diabetes, marking it as the inaugural orally administered medication approved for such ailment in animals.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8095

Which geographic areas are influencing the growth of the pet diabetes care market?

North America was the largest region in the pet diabetes care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Veterinary Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-healthcare-global-market-report

Veterinary Pain Management Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Opportunities are Expected to Drive the Pet Diabetes Care Market’s CAGR Through 2034?

In recent times, a significant surge has been witnessed in the pet diabetes care market, with the market size predicted to swell from $2.21 billion in 2024 to $2.41 billion in 2025, registering a compound annual growth rate (CAGR) of 8.9%. The expansion seen during the historic period is linked to an enhanced consciousness about pet health, breakthroughs in veterinary medical science, a rise in diabetes frequency among pets, the increasing trend of treating pets like humans, amplified emphasis on pet diet standards, initiatives on awareness undertaken by veterinary entities, and the availability of insulin and other related treatments.

In the coming years, the pet diabetes care market is anticipated to witness robust growth, expanding to $3.49 billion in 2029, with a compound annual growth rate (CAGR) of 9.7%. This predicted growth in the forecast period can be linked to an increase in pet insurance uptake, tailored diabetes management for pets, a focus on early pet healthcare, the universal spread of pet health trends, and escalating investment in pet health research and rising consumer wealth. The forecast period also sees significant trends, which encompass advancements in veterinary diagnostic procedures, focus on managing pet obesity, innovations in insulin delivery mechanisms, increased pet insurance coverage, greater accessibility to specialist pet food, telemedicine and remote surveillance, as well as collaborations in veterinary medicine.

Which Primary Drivers Are Supporting the Continued Expansion of the pet diabetes care Market?

Forward growth in the pet diabetes care market is anticipated due to a projected rise in pet adoption. Adopting a pet, which entails acquiring a pet that’s been abandoned by its previous owners from shelters or rescue groups instead of purchasing from breeders, pet stores, or other private entities, is becoming more common. The lifestyle of pets is increasingly aligning with ours as they become less active and depend more on processed foods, leading to a rise in diabetes diagnoses among them. For instance, Animal Medicines Australia, a non-government organization from Australia, reported a noteworthy growth in pet ownership in 2022, climbing to 28,730.8 from a 39% figure in 2021, denoting a 24% surge. This significant rise indicates a steady trend of increased pet adoption and related care investment. As more Australian homes welcome pets, the popularity of pets in Australian homes is increasing. Hence, the upswing in pet adoption is fueling the growth of the pet diabetes care market.

Explore Comprehensive Insights Into The Global Pet Diabetes Care Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

What Are the Leading Industry Players Dominating the Pet Diabetes Care Market?

Major companies operating in the pet diabetes care market are:

• C.H. Boehringer Sohn AG & Co. KG_x000D_

• Becton Dickinson and Company_x000D_

• Merck & Co Inc._x000D_

• Zoetis Inc._x000D_

• Trividia Health Inc._x000D_

What Are the Latest Trends Leading to Disruption in the Pet Diabetes Care Market?

A surge in research and development initiatives, coupled with the introduction of innovative products, is becoming increasingly prevalent in the pet diabetes market. A wealth of research is being undertaken to unravel the complexities of animal diabetes and simplify its management. Additionally, firms are diversifying their offerings through the introduction of generic drugs in a bid to maintain their market stance. For instance, in December 2022, the U.S. Food and Drug Administration (FDA), a governing body focused on scientific regulations, approved a medication for a particular type of feline diabetes developed by Elanco Animal Health Inc. This marked the first-ever oral medication for such animal conditions.

Secure Your Global Pet Diabetes Care Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

What Are the Major Segments of the Pet Diabetes Care Market and Their Role in Driving Growth?

The pet diabetes care market covered in this report is segmented –

1) By Drug Type: Insulin Therapy, Oral Medication

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices

3) By Animal Type: Canine, Feline, Other Animal Types

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals

Subsegments:

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices

2) By Oral Medication: Glipizide, Metformin, Other Oral Hypoglycemic Agents

Which Regions Are Significant to the Growth of the Pet Diabetes Care Market?

North America was the largest region in the pet diabetes care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Pet Diabetes Care Market Classified and Defined in Market Analysis?

Pet diabetes care is used to treat pets suffering from diabetes, which may also cause other diseases such as heart disease, pancreatitis, urinary tract infections, kidney disease, and skin infections. Diabetes develops when a pet’s body produces insufficient insulin, stops generating it altogether, or uses it improperly, which hinders the body from converting food into energy.

Browse Through More Similar Reports By The Business Research Company:

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Veterinary Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-healthcare-global-market-report

Veterinary Pain Management Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: